Columbia, MD, United States of America

Thomas M Fishbein

This inventor holds 2 USPTO granted patents. Top assignee: Medstar Health. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas M Fishbein. Retrieved from https://idiyas.com/inventor/thomas-m-fishbein

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in COVID-19 Treatment by Thomas M Fishbein

Introduction

Thomas M Fishbein is an accomplished inventor based in Columbia, MD (US). He has made significant contributions to the field of medicine, particularly in the treatment of COVID-19. His innovative approach targets the inflammasome/caspase1/pyroptosis axis, which plays a crucial role in the inflammatory response associated with SARS-CoV-2 infections.

Latest Patents

Fishbein holds a patent for "Methods for treating COVID-19." This invention focuses on methods that involve treating patients infected with SARS-CoV-2 using effective amounts of compounds that inhibit the inflammasome/caspase1/pyroptosis axis. His work is particularly relevant in the ongoing fight against the COVID-19 pandemic.

Career Highlights

Currently, Thomas M Fishbein is associated with Medstar Health, where he continues to explore innovative solutions in healthcare. His dedication to research and development has positioned him as a key figure in the medical community.

Collaborations

Some of his notable coworkers include Khalid M Khan and Alexander H Kroemer. Their collaborative efforts contribute to advancing medical research and developing effective treatments.

Conclusion

Thomas M Fishbein's work exemplifies the importance of innovation in addressing global health challenges. His patent for treating COVID-19 highlights his commitment to improving patient outcomes through scientific research and collaboration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…